Hanwha Q Cells became the first company to receive the highest grade under South Korea's carbon certification program for solar modules with seven earning grade 1 certification from the Ministry of Trade, Industry and Energy (MOTIE).
The grade 1 certified modules will be available starting next month, said a Hanwha Q Cells official.
Under the MOTIE’s carbon certification program, the carbon footprint of solar power projects is taken into consideration when prioritizing new installations.
Launched July 22, the program divides solar modules into three categories based on the amount of carbon emitted during its manufacturing and installation.
Grade 1 solar modules, which emit no more than 670 kilograms of carbon per kilowatt of energy generated, are eligible for government subsidies.
The carbon certification program will help reduce carbon emissions from solar modules in South Korea by 10 percent, the equivalent of planting 2 million pine trees or reducing greenhouse gases by 230,000 metric tons annually.


TSMC Exits Arm Holdings with $231 Million Share Sale Amid Strategic Portfolio Shift
Alphabet Earnings Surge on AI Growth, Cloud Revenue, and Strong Search Performance
Qualcomm Stock Surges Despite Weak Guidance After Q2 2026 Earnings Beat
Microsoft Azure Growth Forecast Beats Expectations Amid Rising AI Competition
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds
Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales
China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S.
Seagate Stock Surges After Strong Q3 Earnings Beat and Bullish Outlook
Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List
Amazon Stock Dips Despite Record Earnings as AI Infrastructure Spending Surges
Standard Chartered Q1 Profit Hits Record on Wealth and Investment Banking Growth
Meta Raises 2026 Capex Outlook Amid AI Spending Surge, Shares Drop After Earnings
T-Mobile Beats Q1 Earnings Expectations on Strong Postpaid Growth
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
WuXi AppTec Stock Surges on Strong Q1 Earnings and CRDMO Demand Growth 



